Persistent hyperglycemia is associated with left ventricular dysfunction in patients with acute myocardial infarction

Circulation Journal

Volumn 69, Issue 1, 2005, Pages 23-28

  Kosuge, Masami ^a   Kimura, Kazuo ^a   Ishikawa, Toshiyuki ^a   Shimizi, Tomoaki ^a   Hibi, Kiyoshi ^a   Toda, Noritaka ^a   Tahara, Yoshio ^a   Kanna, Masahiko ^a   Tsukahara, Kengo ^a   Okuda, Jyunn ^a   Nozawa, Naoki ^a   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Glucose; Infarct size; Myocardial infarction

Indexed keywords

CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HUMAN; HYPERGLYCEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; RECANALIZATION; ST SEGMENT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERGLYCEMIA; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 19944433407     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.23     Document Type: Article

References (34)

1. Oswald GA, Corcoran S, Yudkin JS. Prevalence and risk of hyperglycemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1984; 1: 1264-1267.
2. O'Sullivan JJ, Conroy RM, Robinson K, Hickey N, Mulcahy R. Inhospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 1991; 14: 758-760.
3. Fava S, Aquilina O, Azzopardi J, Agius MH, Fenech FF. The prognostic value of blood glucose in diabetic patients with acute myocardial infarction. Diabetic Med 1996; 13: 80-83.
4. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk after myocardial infarction in patients without diabetes: A systematic overview. Lancet 2000; 355: 773-778.
5. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL, ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40: 1748-1754.
6. The TIMI study group. The thrombolysis in myocardial infarction (TIMI) trial: Phase I findings. N Engl J Med 1985; 312: 932-936.
7. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical implications of the 'no reflow' phenomenon: A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996; 93: 223-228.
8. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998; 97: 765-772.
9. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003; 41: 1-7.
10. Van't Hof AWJ, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction. Circulation 1998; 97: 2302-2306.
11. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5: 587-592.
12. Selvester RH, Wagner GS, Hindman NB. The Selvester QRS scoring system for estimating myocardial infarct size: The development and application of the system. Arch Intern Med 1985; 145: 1877-1881.
13. Juergens CP, Fernandes C, Hasche ET, Meikle S, Bautovich G, Currie CA, et al. Electrocardiographic measurement of infarct size after thrombolytic therapy. J Am Coll Cardiol 1996; 27: 617-624.
14. Sandler H, Dodge HT. The use of single plane angiograms for the calculation of left ventricular volume in man. Am Heart J 1968; 75: 325-334.
15. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J, Woo HW. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 1986; 74: 293-305.
16. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med 1989; 320: 618-627.
17. Brodie BR, Stuckey TD, Wall TC, Kissling G, Hansen CJ, Muncy DB, et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998; 32: 1312-1319.
18. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: A prospective study. Lancet 2002; 359: 2140-2144.
19. Tenerz A, Norhammar A, Silveira A, Hamsten A, Nilsson G, Ryden L, et al. Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 2003; 26: 2770-2776.
20. Marfella R, Esposito K, Giunta R, Coppola G, De Angelis L, Farzati B, et al. Circulating adhesion molecules in humans: Role of hyperglycemia and hyperinsulinemia. Circulation 2000; 101: 2247-2251.
21. Hokama JY, Ritter LS, Davis-Gorman G, Cimetta AD, Copeland JG, McDonagh PF. Diabetes enhances leukocyte accumulation in the coronary microcirculation early in reperfusion following ischemia. J Diabetes Complications 2000; 14: 96-107.
22. Shechter M, Merz CN, Paul-Labrador MJ, Kaul S. Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. J Am Coll Cardiol 2000; 35: 300-307.
23. Title LM, Cummings PM, Giddens K, Nassar BA. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: An effect prevented by vitamins C and E. J Am Coll Cardiol 2000; 36: 2185-2191.
24. Fujiwara K, Hiasa Y, Takahashi T, Yamaguchi K, Ogura R, Ohara Y, et al. Influence of diabetes mellitus on outcome in the era of primary stenting for acute myocardial infarction. Circ J 2002; 66: 800-804.
25. Tamada H, Nishikawa H, Mukai S, Setsuda M, Nakamura M, Suzuki H, et al. Impact of diabetes mellitus on angiographically silent coronary atherosclerosis. Circ J 2003; 67: 423-426.
26. Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC. Diabetes abolishes ischemic preconditioning: Role of glucose, insulin, and osmolarity. Am J Physiol Heart Circ Physiol 2000; 278: H1218-H1224.
27. Iwakura K, Ito H, Kawano S, Shintani Y, Yamamoto K, Kato A, et al. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol 2001; 38: 472-477.
28. Kloner RA, Giacomelli F, Alker KJ, Hale SL, Matthews R, Bellows S. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation 1992; 84: 1758-1772.
29. Komamura K, Kitakaze M, Nishida K, Naka M, Tamai J, Uematsu M, et al. Progressive decreases in coronary vein flow during reperfusion in acute myocardial Infarction: Clinical documentation of the no reflow phenomenon after successful thrombolysis. J Am Coll Cardiol 1994; 24: 370-377.
30. Simoons ML, Vos J, Tijssen JG, Vermeer F, Verheugt FW, Krauss XH, et al. Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands. J Am Coll Cardiol 1989; 14: 1609-1615.
31. Ross AM, Coyne KS, Moreyra E, Reiner JS, Greenhouse SW, Walker PL, et al. Extended mortality benefit of early postinfarction reperfusion: GUSTO-I Angiographic Investigators (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial). Circulation 1998; 97: 1549-1556.
32. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: Important risk marker of mortality in conventional treated patients with diabetes mellitus and acute myocardial infarction: Long-term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Circulation 1999; 99: 2626-2632.
33. Diaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalan R, et al. Metabolic modulation of acute myocardial infarction: The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998; 98: 2227-2234.
34. Van der Horst IC, Zijlstra F, van't Hof AW, Doggen CJ, de Boer MJ, Suryapranata H, et al; Zwolle Infarct Study Group. Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: The glucose-insulin-potassium study: A randomized trial. J Am Coll Cardiol 2003; 42: 784-791.